指南与共识其他结缔组织病

中国特发性炎性肌病患者的肿瘤相关肌炎:恶性肿瘤谱、危险因素及IMACS指南验证

Cancer-associated myositis in Chinese patients with idiopathic inflammatory myopathies: Malignancy spectrum, risk factors, and validation of the IMACS guideline.
指南 / 共识 · Semin Arthritis Rheum · 2026-08-07

这项多中心回顾性研究纳入2010年1月至2024年12月中国五家三级转诊中心的1980例成人特发性炎性肌病(IIM)患者,其中176例(8.9%)为肿瘤相关肌炎(CAM),肺癌、乳腺癌和甲状腺癌最常见,76.1%的肿瘤发生在IIM起病前后1年内。IMACS指南将65.9%的CAM患者归为高危,但65.4%的非CAM患者也被归为中危;抗TIF1γ抗体阳性、抗SAE抗体阳性、C反应蛋白升高和CA125升高是独立危险因素,间质性肺病与恶性肿瘤呈负相关。一个纳入抗SAE抗体阳性、C反应蛋白升高、CA125升高和无间质性肺病的细化评分进一步在IMACS分类内分层风险,区分度优于单用IMACS指南(AUC 0.762 vs. 0.699,P < 0.001)。

要点

  • 中国IIM患者中CAM占8.9%,肺癌、乳腺癌、甲状腺癌最常见,76.1%发生于IIM起病前后1年内。
  • 抗TIF1γ抗体阳性、抗SAE抗体阳性、CRP升高和CA125升高是CAM独立危险因素,间质性肺病呈负相关。
  • 细化评分在IMACS分类内进一步分层风险,区分度优于IMACS指南(AUC 0.762 vs. 0.699)。

核心结论

  • IMACS指南能有效识别恶性肿瘤风险升高的IIM患者,一个简单的细化评分可能进一步改善风险分层。

研究设计与样本

  • 多中心回顾性研究,纳入中国五家三级转诊中心2010年1月至2024年12月的1980例成人IIM患者。
  • CAM定义为IIM起病前后3年内诊断的恶性肿瘤。
  • 采用逻辑回归分析识别与恶性肿瘤相关的因素,并开发简化细化评分评估其超越IMACS指南的增量价值。

主要发现

  • 1980例 eligible 患者中176例(8.9%)为CAM。
  • 最常见恶性肿瘤为肺癌(18.2%)、乳腺癌(14.8%)和甲状腺癌(11.9%)。
  • 76.1%的肿瘤发生在IIM起病前后1年内。
  • IMACS指南将65.9%的CAM患者归为高危,65.4%的非CAM患者归为中危。
  • 多变量分析显示抗TIF1γ抗体阳性、抗SAE抗体阳性、CRP升高和CA125升高为独立危险因素,间质性肺病与恶性肿瘤呈负相关。

关键数值与推荐

  • CAM定义为恶性肿瘤在IIM起病前3年内或起病后3年内诊断。
  • 细化评分纳入抗SAE抗体阳性、CRP升高、CA125升高和无间质性肺病,在IMACS分类内进一步分层风险。
  • 细化评分区分度优于IMACS指南(AUC 0.762 vs. 0.699,P < 0.001)。

临床怎么用

  • 对IIM患者应依据IMACS指南评估恶性肿瘤风险,尤其关注起病前后1年内的筛查。
  • 抗TIF1γ抗体阳性、抗SAE抗体阳性、CRP升高或CA125升高的患者可能需更积极肿瘤筛查。
  • 合并间质性肺病的患者恶性肿瘤风险可能较低,但仍需结合其他因素综合判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize malignancy patterns in Chinese patients with idiopathic inflammatory myopathies (IIM) and evaluate the real-world applicability of the International Myositis Assessment and Clinical Studies Group (IMACS) cancer screening guideline. METHODS: This multi-centre retrospective study included adult patients with IIM from five tertiary referral centers in China between January 2010 and December 2024. Cancer-associated myositis (CAM) was defined as malignancy diagnosed within 3 years before or after IIM onset. Logistic regression analyses were performed to identify factors associated with malignancy, and a simplified refinement score was developed to assess its incremental value beyond the IMACS guideline. RESULTS: Among 1980 eligible patients with IIM, 176 (8.9%) had CAM. Lung cancer (18.2%), breast cancer (14.8%), and thyroid cancer (11.9%) were the most common malignancies. Overall, 76.1% of cancers occurred within 1 year before or after IIM onset. According to the IMACS guideline, 65.9% of CAM patients were classified as high-risk, whereas 65.4% of non-CAM patients were also assigned to the moderate-risk category. Multivariable analysis identified anti-TIF1γ antibody positivity, anti-SAE antibody positivity, elevated C-reactive protein, and elevated CA125 as independent risk factors, whereas interstitial lung disease was inversely associated with malignancy. A refinement score incorporating anti-SAE antibody positivity, elevated C-reactive protein, elevated CA125, and absence of interstitial lung disease further stratified malignancy risk within IMACS categories and improved discrimination compared with IMACS alone (AUC 0.762 vs. 0.699, P < 0.001). CONCLUSION: The IMACS guideline effectively identifies patients at increased malignancy risk, and a simple refinement score may further improve risk stratification.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Xia C, Wang R, Lyu X, et al. Cancer-associated myositis in Chinese patients with idiopathic inflammatory myopathies: Malignancy spectrum, risk factors, and validation of the IMACS guideline. Semin Arthritis Rheum. 2026. PMID: 42585765. doi:10.1016/j.semarthrit.2026.153055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。